Publication | Closed Access
Phase I/II trial of tamoxifen with or without fenretinide, an analog of vitamin A, in women with metastatic breast cancer.
72
Citations
12
References
1993
Year
We conclude that tamoxifen administered with fenretinide is nontoxic. Phase III trials of tamoxifen versus tamoxifen plus fenretinide are warranted.
| Year | Citations | |
|---|---|---|
Page 1
Page 1